Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Regulus Therapeutics Inc. | a10k-exx321xcertificationp.htm |
| EX-31.1 - EXHIBIT 31.1 - Regulus Therapeutics Inc. | a10k-exx311xcertificationo.htm |
| 10-K - 10-K - Regulus Therapeutics Inc. | rgls20151231-10k.htm |
| EX-10.32 - EXHIBIT 10.32 - Regulus Therapeutics Inc. | a10k-exx1032xzurichlicagre.htm |
| EX-10.10 - EXHIBIT 10.10 - Regulus Therapeutics Inc. | a10k-exx1010xemploymentagr.htm |
| EX-31.2 - EXHIBIT 31.2 - Regulus Therapeutics Inc. | a10k-exx312xcertificationo.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 Nos. 333-194293 and 333-203292) of Regulus Therapeutics Inc., and
(2) Registration Statement (Form S-8 Nos. 333-184324, 333-188606, 333-194294, 333-201988 and 333-206511) pertaining to the 2009 Equity Incentive Plan, 2012 Equity Incentive Plan and the 2012 Employee Stock Purchase Plan of Regulus Therapeutics Inc.;
of our report dated February 23, 2016, with respect to the financial statements of Regulus Therapeutics Inc. included in this Annual Report (Form 10-K) of Regulus Therapeutics Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
San Diego, California
February 23, 2016